Antibiotics
Louisiana State University announced the results of an early stage clinical trial for treatment of multiple sclerosis. MS patients were given a combination of interferon treatment and the antibiotic doxycycline. These patients had not responded well to interferon treatment alone for the six months prior to the study.
Only 15 patients were in the study, but nine of them had a 25% reduction in brain tissue damage according to MRI results. Disability had improved as well. Doxycycline is part of the tetracycline class of antibiotics which are believed to block an enzyme responsible for nerve damage.
While this is a small study and much research needs to be done, I believe this is very encouraging. We have several experts in this KnowMS.com community on antibiotics and MS, so I encourage people to write comments if they have questions.
Here's the full article.
And here's Alison's Minocycline category for more info about antibiotics and MS.